Trial
NCT02204020
Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Pittsburgh
Collaborators
—
Condition
Acute Myeloid Leukemia (AML)
Intervention
5-azacytidine (5-aza) maintenance therapy after transplant
Why stopped
Lack of interest with investigators - no subjects enrolled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-03-30